RESECTABLE CLEAR CELL RENAL CELL CARCINOMA

Clinical trials for RESECTABLE CLEAR CELL RENAL CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RESECTABLE CLEAR CELL RENAL CELL CARCINOMA trials appear

Sign up with your email to follow new studies for RESECTABLE CLEAR CELL RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug aims to shrink tumors before kidney cancer surgery

Disease control Not yet recruiting

This study is testing if a new immunotherapy drug called ivonescimab can shrink tumors in patients with high-risk kidney cancer that hasn't spread. The drug is given by IV for about 3 months before the patient's standard surgery to remove the kidney. Researchers want to see if th…

Matched conditions: RESECTABLE CLEAR CELL RENAL CELL CARCINOMA

Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Mar 11, 2026 14:52 UTC

RESECTABLE CLEAR CELL RENAL CELL CARCINOMA

Get alerted when new RESECTABLE CLEAR CELL RENAL CELL CARCINOMA trials appear

New drug aims to shrink tumors before kidney cancer surgery